Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Multi-target kinase inhibitor 4

SKU: orb3028496

Description

Multi-target kinase inhibitor 4 (Compound 2) is a PI3K/DNA-PK inhibitor and a potent chemosensitizer that enhances the number of DNA double-strand breaks induced by Doxorubicin. It serves as an effective multidrug resistance (MDR) inhibitor, demonstrating inhibitory activity against P-glycoprotein (P-gp) mediated drug efflux. Multi-target kinase inhibitor 4 can be encapsulated in PEG-coated lipid nanoparticles.

Research Area

Molecular Biology, Neuroscience, Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

TargetP-gp,PI3K,DNA-PK

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Lenvatinib [orb1310532]

    >98%

    417716-92-8

    426.85

    C21H19ClN4O4

    5 mg, 25 mg
  • Ki11502 [orb3133188]

    347155-76-4

    473.54

    C26H23N3O4S

    50 mg, 10 mg
  • XL 999 [orb1301767]

    98.24% (May vary between batches)

    705946-27-6

    445.53

    C26H28FN5O

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
  • Regorafenib mesylate [orb1685949]

    835621-08-4

    578.92

    C22H19ClF4N4O6S

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information